Related Experiment Video
Updated: Jan 27, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Systematic review of biological therapies for atrial fibrillation
Callum McRae1, Anshul Kapoor1, Pushpinder Kanda1
1Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Abstract:
Biological therapies that increase or suppress the expression of transcripts underlying atrial fibrillation (AF) progression are increasingly being explored to create novel treatment paradigms beyond simply suppressing or destroying tissue. To date, there has been no systematic overview of the preclinical evidence exploring manipulation of fundamental biological principles in the treatment of AF. As such, the objective of this study was to establish the effect of biological approaches used in the treatment of AF within large and small animals. We performed a systematic search using predefined terms, which yielded 25 studies. We determined the effect of biological approaches on primary efficacy outcomes and assessed the quality of included studies or possible bias in the treatment of AF. Compared with non-transduced or transduced controls, biological therapies reduced AF inducibility (85% less AF; odds ratio 0.15; 95% confidence interval [CI] 0.07-0.35; P < .01) and atrial scar burden (6.7% smaller scars; 95% CI 4.2-9.2; P < .01) or increased number of days in sinus rhythm (6.4 more days in sinus rhythm; 95% CI 5.83-6.97; P < .01). Similar effects were seen in both large and small animals, while a minor tendency to higher risk of bias was observed in small animal studies. In conclusion, treatment with any biological therapy significantly improved AF in preclinical animal models compared with controls. Although biological therapies target markedly different fundamental mechanisms, we observed a consistent difference in their effect on AF outcomes.
Insights
Biological therapies targeting atrial fibrillation (AF) show significant promise in preclinical animal models. These novel treatments effectively reduce AF inducibility and atrial scarring, offering a new therapeutic avenue beyond traditional methods.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Translational Science
Background:
- Atrial fibrillation (AF) treatment paradigms are evolving beyond tissue ablation.
- Novel therapeutic strategies focus on manipulating biological pathways underlying AF progression.
- Preclinical evidence for biological approaches in AF treatment lacks systematic overview.
Purpose of the Study:
- To systematically review and assess the preclinical evidence of biological therapies for AF treatment in animal models.
- To determine the efficacy of biological approaches in reducing AF burden and improving atrial tissue health.
- To evaluate the quality and potential bias in studies investigating biological treatments for AF.
Main Methods:
- Systematic literature search using predefined terms for biological therapies in AF animal models.
- Analysis of 25 retrieved studies focusing on primary efficacy outcomes.
- Assessment of study quality and risk of bias in included preclinical research.
Main Results:
- Biological therapies significantly reduced AF inducibility by 85% (OR 0.15, P < .01).
- Atrial scar burden was reduced by 6.7% (P < .01), and days in sinus rhythm increased by 6.4 (P < .01).
- Consistent positive effects were observed in both large and small animal models, with a slight trend towards higher bias in smaller animals.
Conclusions:
- Biological therapies demonstrate significant efficacy in improving AF outcomes in preclinical animal models.
- These therapies consistently reduce AF burden and atrial damage, irrespective of the specific biological mechanism targeted.
- Biological approaches represent a promising novel treatment strategy for atrial fibrillation.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Random and Systematic Errors

